Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

398 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A paired-kidney allocation study found superior survival with HLA-DR compatible kidney transplants in the Eurotransplant Senior Program.
de Fijter J, Dreyer G, Mallat M, Budde K, Pratschke J, Klempnauer J, Zeier M, Arns W, Hugo C, Rump LC, Hauser I, Schenker P, Schiffer M, Grimm MO, Kliem V, Olbricht CJ, Pisarski P, Banas B, Suwelack B, Hakenberg O, Berlakovich G, Schneeberger S, van de Wetering J, Berger S, Bemelman F, Kuypers D, Heidt S, Rahmel A, Claas F, Peeters P, Oberbauer R, Heemann U, Krämer BK; Eurotransplant Senior DR-compatible Program (ESDP) Study Group. de Fijter J, et al. Among authors: oberbauer r. Kidney Int. 2023 Sep;104(3):552-561. doi: 10.1016/j.kint.2023.05.025. Epub 2023 Jun 19. Kidney Int. 2023. PMID: 37343659 Free article.
Prospective assessment of pre-existing and de novo anti-HLA IgE in kidney, liver, lung and heart transplantation.
Mucha J, Cho A, Weijler AM, Muckenhuber M, Hofmann AG, Wahrmann M, Heinzel A, Linhart B, Gattinger P, Valenta R, Berlakovich G, Zuckermann A, Jaksch P, Oberbauer R, Wekerle T. Mucha J, et al. Among authors: oberbauer r. Front Immunol. 2023 Sep 5;14:1179036. doi: 10.3389/fimmu.2023.1179036. eCollection 2023. Front Immunol. 2023. PMID: 37731514 Free PMC article.
Combination cell therapy leads to clonal deletion of donor-specific T cells in kidney transplant recipients.
David AF, Heinzel A, Kammer M, Aschauer C, Reindl-Schwaighofer R, Hu K, Chen HS, Muckenhuber M, Kubetz A, Weijler AM, Worel N, Edinger M, Berlakovich G, Lion T, Sykes M, Wekerle T, Oberbauer R. David AF, et al. Among authors: oberbauer r. EBioMedicine. 2024 Aug;106:105239. doi: 10.1016/j.ebiom.2024.105239. Epub 2024 Jul 13. EBioMedicine. 2024. PMID: 38996766 Free PMC article. Clinical Trial.
Cardiovascular Outcomes in De Novo Kidney Transplant Recipients Receiving Everolimus and Reduced Calcineurin Inhibitor or Standard Triple Therapy: 24-month Post Hoc Analysis From TRANSFORM Study.
Sommerer C, Legendre C, Citterio F, Watarai Y, Oberbauer R, Basic-Jukic N, Han J, Gawai A, Bernhardt P, Chadban S. Sommerer C, et al. Among authors: oberbauer r. Transplantation. 2023 Jul 1;107(7):1593-1604. doi: 10.1097/TP.0000000000004555. Epub 2023 Jun 20. Transplantation. 2023. PMID: 36959121
Development and Validation of a Prediction Model for Future Estimated Glomerular Filtration Rate in People With Type 2 Diabetes and Chronic Kidney Disease.
Gregorich M, Kammer M, Heinzel A, Böger C, Eckardt KU, Heerspink HL, Jung B, Mayer G, Meiselbach H, Schmid M, Schultheiss UT, Heinze G, Oberbauer R; BEAt-DKD Consortium. Gregorich M, et al. Among authors: oberbauer r. JAMA Netw Open. 2023 Apr 3;6(4):e231870. doi: 10.1001/jamanetworkopen.2023.1870. JAMA Netw Open. 2023. PMID: 37017968 Free PMC article.
Different roles of protein biomarkers predicting eGFR trajectories in people with chronic kidney disease and diabetes mellitus: a nationwide retrospective cohort study.
Kammer M, Heinzel A, Hu K, Meiselbach H, Gregorich M, Busch M, Duffin KL, Gomez MF, Eckardt KU, Oberbauer R; BEAt-DKD consortium. Kammer M, et al. Among authors: oberbauer r. Cardiovasc Diabetol. 2023 Mar 29;22(1):74. doi: 10.1186/s12933-023-01808-5. Cardiovasc Diabetol. 2023. PMID: 36991445 Free PMC article.
Cilgavimab and tixagevimab as pre-exposure prophylaxis in vaccine non-responder kidney transplant recipients during a period of prevalent SARS-CoV-2 BA.2 and BA.4/5 variants-a prospective cohort study (RESCUE-TX).
Reindl-Schwaighofer R, Heinzel A, Raab L, Strassl R, Herz CT, Regele F, Doberer K, Helk O, Spechtl P, Aschauer C, Hu K, Jagoditsch R, Reiskopf B, Böhmig GA, Benka B, Mahr B, Stiasny K, Weseslindtner L, Kammer M, Wekerle T, Oberbauer R. Reindl-Schwaighofer R, et al. Among authors: oberbauer r. EBioMedicine. 2024 Nov;109:105417. doi: 10.1016/j.ebiom.2024.105417. Epub 2024 Oct 22. EBioMedicine. 2024. PMID: 39442367 Free PMC article.
Association of urinary EGF, FABP3, and VCAM1 levels with the progression of early diabetic kidney disease.
Keller F, Denicolò S, Leierer J, Kruus M, Heinzel A, Kammer M, Ju W, Nair V, Burdet F, Ibberson M, Menon R, Otto E, Choi YJ, Pyle L, Ladd P, Bjornstad PM, Eder S, Rosivall L, Mark PB, Wiecek A, Heerspink HJL, Kretzler M, Oberbauer R, Mayer G, Perco P. Keller F, et al. Among authors: oberbauer r. Kidney Blood Press Res. 2024 Nov 7:1-21. doi: 10.1159/000542267. Online ahead of print. Kidney Blood Press Res. 2024. PMID: 39510044 Free article.
Renin-angiotensin system inhibitor discontinuation in COVID-19 did not modify systemic ACE2 in a randomized controlled trial.
Rathkolb V, Traugott MT, Heinzel A, Poglitsch M, Aberle J, Eskandary F, Abrahamowicz A, Mueller M, Knollmueller P, Shoumariyeh T, Stuflesser J, Seeber I, Gibas G, Mayfurth H, Tinhof V, Schmoelz L, Zeitlinger M, Schoergenhofer C, Jilma B, Genser B, Hoepler W, Omid S, Karolyi M, Wenisch C, Oberbauer R, Zoufaly A, Hecking M, Reindl-Schwaighofer R. Rathkolb V, et al. Among authors: oberbauer r. iScience. 2023 Oct 5;26(11):108146. doi: 10.1016/j.isci.2023.108146. eCollection 2023 Nov 17. iScience. 2023. PMID: 37867935 Free PMC article.
398 results